Article Figures & Data
Figures
- Figure.
Three-month outcome of patients under GA compared with patients with CS. The figures in the bar indicate the percentage of patients with a given mRS at 3-month follow-up.
Tables
CS GA P Value No. of patients 135 266 Age (yr) (mean) (SD) 70.5 (14.9) 70.9 (13.9) .803 Age older than 80 yr 46 (34.1) 76 (28.6) .258 Male sex 59 (43.7) 140 (52.6) .091 Prestroke mRS < 1 124 (94.7) 228 (89.8) .104 TOAST .162 Large-artery disease 26 (19.3) 63 (23.8) Small-artery disease 3 (2.2) 6 (2.3) Cardioembolism 64 (47.4) 95 (35.8) Stroke of other determined etiology 15 (11.1) 23 (8.7) Stroke of undetermined etiology 27 (20) 78 (29.5) Atrial fibrillation 39 (31.2) 84 (36.5) .164 Hyperlipidemia 59 (44.4) 120 (45.8) .786 Arterial hypertension 66 (48.9) 146 (54.9) .255 Diabetes mellitus 39 (29.3) 74 (28.2) .823 Coronary disease 21 (17.4) 65 (27.3) .037 Smoking 49 (38.9) 111 (46.3) .177 Prior stroke or TIA 15 (14.2) 32 (14.4) .949 Recurrent stroke within 3 mo 9 (7.8) 11 (4.9) .462 NIHSS on admission (mean) (SD) 13.1 (5.7) 17.2 (6.6) <.001 Vessel occlusion site <.001 ICA 20 (14.8) 117 (44) ACA 1 (0.7) 0 (0) MCA 114 (84.4) 149 (56) Time from symptom onset to start of EVT (mean) (SD) (min) 277 (126) 299 (157) .165 Intravenous rtPA and EVT 44 (32.6) 78 (29.3) .501 Mechanical thrombectomy only 72 (53.3) 159 (59.8) .217 Maximal systolic blood pressure (mm Hg) (mean) (SD) 177 (25) 176 (25) .631 Minimal systolic blood pressure (mm Hg) (mean) (SD) 149 (33) 133 (42) <.001 Systolic BP gradient during procedure (mm Hg) (mean) (SD) 31 (26) 50 (32) <.001 BP-increasing drugs 54 (40.3) 254 (95.8) <.001 BP-lowering drugs 42 (31.1) 104 (39.1) .116 TICI 2–3 recanalization 116 (85.9) 235 (88.3) .488 3-month mRS 0–1 37 (27.4) 56 (21.2) .154 3-month mRS 0–2 64 (47.4) 85 (32) .002 NIHSS after 24 hr (mean) (SD) 9 (8.3) 13.9 (11.2) <.001 Death within 3 months 28 (20.7) 77 (28.9) .077 Note:—ACA indicates anterior cerebral artery; BP, blood pressure.
↵a Data are No. (%) unless otherwise indicated.
- Table 2:
Peri- and postprocedural complications of endovascular treatment with the Solitaire stent retriever in anterior circulation strokea
CS GA P Value Pneumonia 22 (16.5) 67 (25.3) .048 Symptomatic ICH (PROACT II) 9 (6.8) 20 (7.6) .755 Symptomatic ICH (ECASS II) 9 (6.8) 21 (8) .658 Systemic bleeding 4 (3) 3 (1.1) .185 Asymptomatic ICH (PROACT II) 24 (18) 52 (19.9) .655 Peri-interventional complications Dissection 6 (4.5) 12 (4.6) .975 Thrombus dislocation 12 (9) 33 (12.5) .302 Perforation of intracranial vessels 2 (1.5) 5 (1.9) .773 Note:—ICH indicates intracerebral hemorrhage.
↵a Data are No. (%) unless otherwise indicated.
Odds Ratio (95% CI) P Value GA 0.873 (0.505–1.512) .629 Age 0.95 (0.932–0.969) <.001 NIHSS 0.894 (0.855–0.933) <.001 Time from symptom onset to start of EVT 0.998 (0.996–0.999) .01 Symptomatic ICH 0.109 (0.028–0.428) .002 Diabetes mellitus 0.544 (0.305–0.972) .04 Note:—ICH indicates intracerebral hemorrhage.
